Du är nu på väg att lämna en GSK-hemsida

Denna länk leder till en hemsida som inte tillhör GSK. GSK tar inget ansvar för innehållet på tredje parts hemsidor.

Fortsätt

Tillbaka

GSK Highlights from ERS 2019

Lunchtime session: an update on chronic obstructive pulmonary disease

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/Health/Sweden/se-ers-2019-daily-video-highlights-alvar-agusti.mp4


Professor Alvar Augusti 

University of Barcelona, Spain

References:

  1. Agusti A;The European respiratory journal;2016;47;410-419, (KC)
  2. Agusti A;The Lancet. Respiratory medicine;2019;7;358-364
  3. Global Initiative for Chronic Obstructive Lung Disease;GOLD;2019;1-151
  4. Pinkerton KE;American journal of respiratory and critical care medicine;2015;192;11-16

 
COPD Symposium video presentation - Welcome and Introduction

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/Health/Sweden/ers-2019-copd-symposium-prof-agusti-welcome-and-introduction.mp4


Professor Alvar Augusti  

University of Barcelona, Spain

 
References:

  1. Agusti A;The New England Journal of Medicine;2019;381;1248-56

 
COPD symposium video - Are we doing too little too late in COPD

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/Health/Sweden/ers-2019-copd-symposium-are-we-doing-too-little-too-late.mp4


Professor Paul Jones   

Global Medical Expert, GSK

 
References:

  1. Agusti A;Respiratory research;2010;11;122, (KC)
  2. Agusti A;The Lancet. Respiratory medicine;2019;7;358-364
  3. Rabe KF;American journal of respiratory and critical care medicine;2007;176;532-555

 
COPD Symposium video presentation - Prof. David Newby

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/Health/Sweden/ers-2019-copd-symposium-prof-newby.mp4


Professor David Newby   

University of Edinburgh, UK

 
References:

  1. Adamson PD;Journal of cardiovascular computed tomography;2019;13;54-58
  2. Antiplatelet Trialists' Collaboration; British Medical Journal;1994;308;81-106
  3. Cholesterol Treatment Trialists’ (CTT) Collaborators;Lancet;2012;380;581-590
  4. Davies MJ;Heart;2000;83;361-366
  5. Newby D;ESC;2019;1-20
  6. Newby D;Society of Cardiovascular Computed Tomography;2019;1-25
  7. Newby DE;Trials;2012;13:1-13
  8. SCOT-HEART investigators;Lancet; 2015;385:2383-91
  9. SCOT-HEART investigators;N Engl J Med;2018;379:924-33
  10. Sekhri N;Heart;2007;93:458–463
  11. Supplementary Appendix - SCOT-HEART investigators;N Engl J Med;2018;379:1-22
  12. WHO;Deaths from coronary heart disease;2019;48-49